ISM PHARMA LTDActive
Key figures
Like most small UK companies, ISM PHARMA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | 171,335 | — | — | — | — |
| Cash at bank and in hand | 688,611 | 466,800 | 456,757 | 397,997 | 430,626 |
| Total assets | 2,663,833 | 2,358,779 | 2,251,712 | 2,007,208 | 1,945,717 |
| Total liabilities | 2,417,931 | 2,152,529 | 2,088,502 | 1,957,578 | 1,990,376 |
| Net assets / total equity | 242,022 | 201,516 | 153,574 | 40,319 | -51,945 |
| Average number of employees | 18 | 16 | 19 | 19 | 15 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025community pharmacy
As described in the company's latest filed accounts.
Summary: ISM PHARMA LTD
Company
ISM PHARMA LTD is a private limited company registered with Companies House under company number 11050737. It was incorporated on 7 Nov 2017. Its status is active. The registered office is in London (W1T). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Nov 2025); the company files small company accounts (filleted). Net assets were −£51,945, down 228.8% on the previous year. Cash at bank and in hand was £430,626. Total assets were £1,945,717 and total liabilities £1,990,376. The company had an average of 15 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
2 persons with significant control are registered. 3 of 3 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Aug 2027. The next confirmation statement is due by 27 Feb 2027.